AAAAAA

   
Results: 1-25 | 26-48
Results: 1-25/48
Technical challenges of hepatic venous outflow reconstruction in right lobe adult living donor liver transplantation
Authors: Ghobrial, RM Hsieh, CB Lerner, S Winters, S Nissen, N Dawson, S Amersi, F Chen, P Farmer, D Yersiz, H Busuttil, RW
Citation: Rm. Ghobrial et al., Technical challenges of hepatic venous outflow reconstruction in right lobe adult living donor liver transplantation, LIVER TRANS, 7(6), 2001, pp. 551-555
Induction of long-term islet allograft survival in two rat strains by a single allochimeric class I MHC molecule
Authors: Tanabe, Y Omori, K Hao, D Valiente, L Maruyama, M Smith, CV Weglinski, JK Busuttil, RW Mulen, Y Ghobrial, RM
Citation: Y. Tanabe et al., Induction of long-term islet allograft survival in two rat strains by a single allochimeric class I MHC molecule, TRANSPLAN P, 33(1-2), 2001, pp. 157-158
Allochimeric class I MHC inhibits chronic rejection in cardiac allografts
Authors: Singer, JS Shen, X Fishbein, M Mhoyan, A Zhao, D Reemsteen, B Gao, F Amersi, F Coito, AJ Busuttil, RW Weglinski, JK Ghobrial, RM
Citation: Js. Singer et al., Allochimeric class I MHC inhibits chronic rejection in cardiac allografts, TRANSPLAN P, 33(1-2), 2001, pp. 179-179
Amelioration of hepatic ischemia/reperfusion injury with intercellular adhesion molecule-1 antisense oligodeoxynucleotides
Authors: Ghobrial, R Amersi, F Stecker, K Kato, H Melinek, J Singer, J Mhoyan, A Busuttil, RW Kupiec-Weglinski, JW Stepkowski, SM
Citation: R. Ghobrial et al., Amelioration of hepatic ischemia/reperfusion injury with intercellular adhesion molecule-1 antisense oligodeoxynucleotides, TRANSPLAN P, 33(1-2), 2001, pp. 538-538
Heme oxygenase-1 gene therapy: A novel immunomodulatory approach in liver allograft recipients?
Authors: Ke, B Shen, XD Melinek, J Gao, F Ritter, T Volk, HD Busuttil, RW Kupiec-Weglinski, JW
Citation: B. Ke et al., Heme oxygenase-1 gene therapy: A novel immunomodulatory approach in liver allograft recipients?, TRANSPLAN P, 33(1-2), 2001, pp. 581-582
Allochimeric class I MHC molecules prevent chronic rejection and attenuatealloantibody responses
Authors: Singer, JS Mhoyan, A Fishbein, MC Shen, XD Gao, F Zhao, DY Coito, AJ Reemtsen, BL Amersi, F Busuttil, RW Kupiec-Weglinski, JW Ghobrial, RM
Citation: Js. Singer et al., Allochimeric class I MHC molecules prevent chronic rejection and attenuatealloantibody responses, TRANSPLANT, 72(8), 2001, pp. 1408-1416
Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants
Authors: Markmann, JF Markmann, JW Markmann, DA Bacquerizo, A Singer, J Holt, CD Gornbein, J Yersiz, H Morrissey, M Lerner, SM McDiarmid, SV Busuttil, RW
Citation: Jf. Markmann et al., Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants, TRANSPLANT, 72(6), 2001, pp. 1113-1122
Evidence of T cell clonality in the infectious tolerance pathway: Implications toward identification of regulatory T cells
Authors: Zhai, Y Li, JY Hammer, M Busuttil, RW Volk, HD Kupiec-Weglinski, JW
Citation: Y. Zhai et al., Evidence of T cell clonality in the infectious tolerance pathway: Implications toward identification of regulatory T cells, TRANSPLANT, 71(12), 2001, pp. 1701-1708
Novel iron chelator in combination with a P-selectin antagonist prevents ischemia/reperfusion injury in a rat liver model
Authors: Amersi, F Dulkanchainun, T Nelson, SK Farmer, DG Kato, H Zaky, J Melinek, J Shaw, GD Kupiec-Weglinski, JW Horwitz, LD Horwitz, MA Busuttil, RW
Citation: F. Amersi et al., Novel iron chelator in combination with a P-selectin antagonist prevents ischemia/reperfusion injury in a rat liver model, TRANSPLANT, 71(1), 2001, pp. 112-118
Elevated body mass disrupts the barrier to gastroesophageal reflux - Discussion
Authors: Pellegrini, C Finley, RJ Busuttil, RW Bremner, CG
Citation: C. Pellegrini et al., Elevated body mass disrupts the barrier to gastroesophageal reflux - Discussion, ARCH SURG, 136(9), 2001, pp. 1018-1019
Outcome after intestinal transplantation - Results from one center's 9-year experience
Authors: Farmer, DG McDiarmid, SV Yersiz, H Cortina, G Amersi, FI Vargas, J Gershman, C Ament, M Busuttil, RW
Citation: Dg. Farmer et al., Outcome after intestinal transplantation - Results from one center's 9-year experience, ARCH SURG, 136(9), 2001, pp. 1027-1031
Outcome after intestinal transplantation - Results from one center's 9-year experience - Discussion
Authors: Wolfe, BM Busuttil, RW
Citation: Bm. Wolfe et Rw. Busuttil, Outcome after intestinal transplantation - Results from one center's 9-year experience - Discussion, ARCH SURG, 136(9), 2001, pp. 1032-1032
A 10-year experience of liver transplantation for hepatitis C: Analysis offactors determining outcome in over 500 patients
Authors: Ghobrial, RM Steadman, R Gornbein, J Lassman, C Holt, CD Chen, P Farmer, DG Yersiz, H Danino, N Collisson, E Baquarizo, A Han, SS Saab, S Goldstein, LI Donovan, JA Esrason, K Busuttil, RW
Citation: Rm. Ghobrial et al., A 10-year experience of liver transplantation for hepatitis C: Analysis offactors determining outcome in over 500 patients, ANN SURG, 234(3), 2001, pp. 384-393
Clinical intestinal transplantation: A decade of experience at a single center - Discussion
Authors: Busuttil, RW Abu-Elmagd, K Tzakis, AG
Citation: Rw. Busuttil et al., Clinical intestinal transplantation: A decade of experience at a single center - Discussion, ANN SURG, 234(3), 2001, pp. 416-417
Role of plasmapheresis in the management of acute hepatic failure in children - Discussion
Authors: Busuttil, RW Singer, AL Miller, CM
Citation: Rw. Busuttil et al., Role of plasmapheresis in the management of acute hepatic failure in children - Discussion, ANN SURG, 234(3), 2001, pp. 424-424
An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy
Authors: Han, SHB Ofman, J Holt, C King, K Kunder, G Chen, P Dawson, S Goldstein, L Yersiz, H Farmer, DG Ghobrial, RM Busuttil, RW Martin, P
Citation: Shb. Han et al., An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy, LIVER TRANS, 6(6), 2000, pp. 741-748
Endoscopic management of biliary leaks after T-tube removal in liver transplant recipients: Nasobiliary drainage versus biliary stenting
Authors: Saab, S Martin, P Soliman, GY Machicado, GA Roth, BE Kunder, G Han, SHB Farmer, DG Ghobrial, RM Busuttil, RW Bedford, RA
Citation: S. Saab et al., Endoscopic management of biliary leaks after T-tube removal in liver transplant recipients: Nasobiliary drainage versus biliary stenting, LIVER TRANS, 6(5), 2000, pp. 627-632
Quinupristin/dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium
Authors: Winston, DJ Emmanouilides, C Kroeber, A Hindler, J Bruckner, DA Territo, MC Busuttil, RW
Citation: Dj. Winston et al., Quinupristin/dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium, CLIN INF D, 30(5), 2000, pp. 790-797
Adult-to-adult living-donor liver transplantation: A critical analysis
Authors: Renz, JF Busuttil, RW
Citation: Jf. Renz et Rw. Busuttil, Adult-to-adult living-donor liver transplantation: A critical analysis, SEM LIV DIS, 20(4), 2000, pp. 411-424
Transjugular intrahepatic portosystemic shunts in patients with hepatocellular carcinoma
Authors: Lerner, S Busuttil, RW
Citation: S. Lerner et Rw. Busuttil, Transjugular intrahepatic portosystemic shunts in patients with hepatocellular carcinoma, J CLIN GAST, 31(3), 2000, pp. 193-194
Improved outcome after intestinal transplantation: An 8-year, single-center experience
Authors: Farmer, DG McDiarmid, SV Yersiz, H Cortina, G Restrepo, GC Amersi, F Vargas, J Gershman, G Ament, M Reyen, L Le, H Ghobrial, RM Chen, P Dawson, S Han, S Martin, P Goldstein, L Busuttil, RW
Citation: Dg. Farmer et al., Improved outcome after intestinal transplantation: An 8-year, single-center experience, TRANSPLAN P, 32(6), 2000, pp. 1233-1234
Adenovirus-mediated gene transfer of IL-4 prolongs rat renal allograft survival and inhibits the p21(ras)-activation pathway
Authors: Kato, H Ritter, T Ke, B Murakami, M Kusano, M Busuttil, RW Kupiec-Weglinski, JW
Citation: H. Kato et al., Adenovirus-mediated gene transfer of IL-4 prolongs rat renal allograft survival and inhibits the p21(ras)-activation pathway, TRANSPLAN P, 32(2), 2000, pp. 245-246
The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients
Authors: Younes, BS McDiarmid, SV Martin, MG Vargas, JH Goss, JA Busuttil, RW Ament, ME
Citation: Bs. Younes et al., The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients, TRANSPLANT, 70(1), 2000, pp. 94-99
Fas ligand gene transfer prolongs rat renal allograft survival and down-regulates anti-apoptotic Bag-1 in parallel with enhanced Th2-type cytokine expression
Authors: Ke, BB Coito, AJ Kato, H Zhai, Y Wang, T Sawitzki, B Seu, P Busuttil, RW Kupiec-Weglinski, JW
Citation: Bb. Ke et al., Fas ligand gene transfer prolongs rat renal allograft survival and down-regulates anti-apoptotic Bag-1 in parallel with enhanced Th2-type cytokine expression, TRANSPLANT, 69(8), 2000, pp. 1690-1694
Regulatory cells potentiate the efficacy of IL-4 gene transfer by up-regulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients
Authors: Ke, BB Ritter, T Kato, H Zhai, Y Li, JY Lehmann, M Busuttil, RW Volk, HD Kupiec-Weglinski, JW
Citation: Bb. Ke et al., Regulatory cells potentiate the efficacy of IL-4 gene transfer by up-regulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients, J IMMUNOL, 164(11), 2000, pp. 5739-5745
Risultati: 1-25 | 26-48